These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36647979)

  • 21. Levels of hepatocyte growth factor in serum correlate with quality of life in hemodialysis patients.
    Baum E; Pawlaczyk K; Maćkowiak B; Sosinska P; Matecka M; Kolodziejczak B; Musielak M; Breborowicz A
    Int J Clin Exp Pathol; 2015; 8(10):13477-82. PubMed ID: 26722560
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatocyte growth factor (HGF) and hemodialysis: physiopathology and clinical implications.
    Libetta C; Esposito P; Martinelli C; Grosjean F; Gregorini M; Rampino T; Dal Canton A
    Clin Exp Nephrol; 2016 Jun; 20(3):371-8. PubMed ID: 26676905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.
    Rangel-López A; Paniagua-Medina ME; Urbán-Reyes M; Cortes-Arredondo M; Alvarez-Aguilar C; López-Meza J; Ochoa-Zarzosa A; Lindholm B; García-López E; Paniagua JR
    Mutagenesis; 2013 Mar; 28(2):219-25. PubMed ID: 23408844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sevelamer revisited: pleiotropic effects on endothelial and cardiovascular risk factors in chronic kidney disease and end-stage renal disease.
    Rastogi A
    Ther Adv Cardiovasc Dis; 2013 Dec; 7(6):322-42. PubMed ID: 24327730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased Inflammatory Response in Association with the Initiation of Hemodialysis Compared with Peritoneal Dialysis in a Prospective Study of End-Stage Kidney Disease Patients.
    Yong K; Dogra G; Boudville N; Lim W
    Perit Dial Int; 2018; 38(1):18-23. PubMed ID: 29097485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased aortic wall stiffness associated with low circulating fetuin A and high C-reactive protein in predialysis patients.
    Porazko T; Kuźniar J; Kusztal M; Kuźniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephron Clin Pract; 2009; 113(2):c81-7. PubMed ID: 19602903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. THE ROLE OF OXIDATIVE STRESS IN PATIENTS WITH CHRONIC KIDNEY DISEASE.
    Al-Badry SH; Ibrahim NG; AlMashhadani HA; Kadhim MM
    Wiad Lek; 2023; 76(5 pt 1):951-955. PubMed ID: 37326075
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of hepatocyte growth factor/activin A/follistatin system during hemodialysis: role of heparin.
    Borawski J; Naumnik B; Myśliwiec M
    Kidney Int; 2003 Dec; 64(6):2229-37. PubMed ID: 14633147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of peritoneal dialysis and hemodialysis on arterial stiffness compared with predialysis patients.
    Yang L; Lin Y; Ye C; Mao Z; Rong S; Zhao X; Mei C
    Clin Nephrol; 2011 Mar; 75(3):188-94. PubMed ID: 21329628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduced endothelial progenitor cells in children with hemodialysis but not predialysis chronic kidney disease.
    Jie KE; Lilien MR; Goossens MH; Westerweel PE; Klein MK; Verhaar MC
    Pediatrics; 2010 Oct; 126(4):e990-3. PubMed ID: 20819900
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial dysfunction, inflammation and atherosclerosis in chronic kidney disease--a cross-sectional study of predialysis, dialysis and kidney-transplantation patients.
    Recio-Mayoral A; Banerjee D; Streather C; Kaski JC
    Atherosclerosis; 2011 Jun; 216(2):446-51. PubMed ID: 21414625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predialysis nephrology care and its impact on initial vascular access type in hemodialysis patients in Jordan.
    Hamadah AM; Gharaibeh K
    Saudi J Kidney Dis Transpl; 2019; 30(5):1103-1110. PubMed ID: 31696849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A predictive model of progression of CKD to ESRD in a predialysis pediatric interdisciplinary program.
    Cerqueira DC; Soares CM; Silva VR; Magalhães JO; Barcelos IP; Duarte MG; Pinheiro SV; Colosimo EA; Simões e Silva AC; Oliveira EA
    Clin J Am Soc Nephrol; 2014 Apr; 9(4):728-35. PubMed ID: 24458086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship between renal function and plasma concentration of the cachectic factor zinc-alpha2-glycoprotein (ZAG) in adult patients with chronic kidney disease.
    Pelletier CC; Koppe L; Alix PM; Kalbacher E; Croze ML; Hadj-Aissa A; Fouque D; Guebre-Egziabher F; Soulage CO
    PLoS One; 2014; 9(7):e103475. PubMed ID: 25076420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels of serum hepatocyte growth factor in patients with end-stage renal disease.
    Lohr JW; Lee TP; Farooqui M; Mookerjee BK
    J Med; 2000; 31(3-4):131-41. PubMed ID: 11280445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice.
    Yang J; Dai C; Liu Y
    Gene Ther; 2001 Oct; 8(19):1470-9. PubMed ID: 11593360
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocyte growth factor exerts beneficial effects on mice with type II diabetes‑induced chronic renal failure via the NF‑κB pathway.
    Cheng G; Tang X; Zhang J
    Mol Med Rep; 2018 Sep; 18(3):3389-3396. PubMed ID: 30066918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma Urotensin II levels in children and adolescents with chronic kidney disease: a single-centre study.
    Garoufi A; Drapanioti S; Marmarinos A; Askiti V; Mitsioni AJ; Mila M; Grigoriadou G; Georgakopoulos D; Stefanidis CJ; Gourgiotis D
    BMC Nephrol; 2017 Mar; 18(1):113. PubMed ID: 28359257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of methoxy polyethylene glycol-epoetin beta on oxidative stress in predialysis patients with chronic kidney disease.
    Bartnicki P; Fijałkowski P; Majczyk M; Błaszczyk J; Banach M; Rysz J
    Med Sci Monit; 2013 Nov; 19():954-9. PubMed ID: 24201565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors of microinflammation in non-diabetic chronic kidney disease: a pilot study.
    Olivier V; Dunyach-Remy C; Corbeau P; Cristol JP; Sutra T; Burtey S; Lavigne JP; Moranne O
    BMC Nephrol; 2020 Apr; 21(1):141. PubMed ID: 32316931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.